NBR2/miR-561-5p/DLC1 axis inhibited the development of multiple myeloma by activating the AMPK/mTOR pathway to repress glycolysis / Chang-Sheng Wang ... [et al.]. Neoplasma Vol. 69, no. 5 (2022), s. 1165-1174